APA

Mowbray C. E., Burt C., Corbau R., Gayton S., Hawes M., Perros M., Tran I., Price D. A., Quinton F. J., Selby M. D., Stupple P. A., Webster R. & Wood A. (20100105). Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate. : Bioorganic & medicinal chemistry letters.

Chicago

Mowbray Charles E, Burt Catherine, Corbau Romuald, Gayton Simon, Hawes Michael, Perros Manos, Tran Isabelle, Price David A, Quinton Faye J, Selby Matthew D, Stupple Paul A, Webster Rob and Wood Anthony. 20100105. Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate. : Bioorganic & medicinal chemistry letters.

Harvard

Mowbray C. E., Burt C., Corbau R., Gayton S., Hawes M., Perros M., Tran I., Price D. A., Quinton F. J., Selby M. D., Stupple P. A., Webster R. and Wood A. (20100105). Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate. : Bioorganic & medicinal chemistry letters.

MLA

Mowbray Charles E, Burt Catherine, Corbau Romuald, Gayton Simon, Hawes Michael, Perros Manos, Tran Isabelle, Price David A, Quinton Faye J, Selby Matthew D, Stupple Paul A, Webster Rob and Wood Anthony. Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate. : Bioorganic & medicinal chemistry letters. 20100105.